Skip to main content

Veracyte, Inc.

VCYT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001384101

In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Veracyte, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
6 insiders, $1.31M in total
Insiders trading
6
Net value
−$1.31M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Veracyte, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Veracyte, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Leite JohnGlobal Chief Commercial Off124,329Sep 22, 202610
Holstein JensDirector27,471Sep 16, 20263
Wygant JonathanVP, Chief Accounting Officer43,226Sep 4, 20268
Febbo Phillip G.Chief Scientific & Med Officer133,048Sep 4, 20267
Chambers RebeccaChief Financial Officer166,025Sep 4, 20268
McGuire AnnieEVP, General Counsel131,160Sep 4, 202611
Stapley MarcChief Executive Officer432,073Sep 4, 20267
Bhanji MunaDirector42,718Sep 3, 20262
Eastham KarinDirector15,097Jun 22, 20264
Jones Evan/ FaDirector34,634Jun 15, 20263
Epstein Robert SDirector57,718Jun 15, 20263
Shafer David BrentDirector31,100Jun 15, 20261
Barr EliavDirector56,461Jun 15, 20261
Miller Thomas F.Director31,100Jun 15, 20261
Haas Kevin RichardChief Dev and Tech Officer44,221Apr 14, 20261
Bishop John LDirector33,125Jul 19, 20230
Anderson Bonnie HDirector41,377Jun 6, 20230
Kennedy Giulia CChief Scientific & Med Officer65,970Dec 8, 20220
Gordon Kevin KDirector8,720Jun 10, 20220
Nova Tina SusanPresident, CLIA U.S.76,988Mar 7, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2024 (view filing)Dec 42 daysFebbo Phillip G.Chief Scientific & Med OfficerSSale−3.93K$44.09−$173.5K−4.6%82.4K after10b5-1
Dec 6, 2024 (view filing)Dec 42 daysMcGuire AnnieSVP, General CounselSSale−18.7K$44.02−$823.1K−20.4%72.9K after10b5-1
Dec 4, 2024 (view filing)Dec 31 dayLeite JohnChief Commercial Officer-CLIASSale−1.05K$43.25−$45.4K−1.4%73.8K after
Dec 4, 2024 (view filing)Dec 31 dayChambers RebeccaChief Financial OfficerSSale−7.00K$43.23−$302.6K−5.8%114.0K after10b5-1
Dec 4, 2024 (view filing)Dec 31 dayWygant JonathanVP, Chief Accounting OfficerSSale−956$43.36−$41.5K−2.3%40.3K after
Nov 29, 2024 (view filing)Nov 272 daysWygant JonathanVP, Chief Accounting OfficerSSale−5.03K$42.89−$215.8K−10.6%42.3K after
Nov 21, 2024 (view filing)Nov 192 daysEastham KarinDirectorSSale−14.7K$38.34−$564.8K−44.3%18.5K after3 lots10b5-1
Nov 14, 2024 (view filing)Nov 122 daysChambers RebeccaChief Financial OfficerSSale−15.3K$38.34−$585.6K−10.9%124.5K after10b5-1
Nov 14, 2024 (view filing)Nov 122 daysEpstein Robert SDirectorSSale−15.0K$38.32−$574.8K−25.2%44.6K after10b5-1
Sep 23, 2024 (view filing)Sep 194 daysJones Evan/ FaDirectorSSale−5.17K$35.23−$182.2K−100.0%0 after10b5-1
Sep 6, 2024 (view filing)Sep 42 daysLeite JohnChief Commercial Officer-CLIASSale−5.48K$29.78−$163.2K−6.7%76.2K after10b5-1
Aug 14, 2024 (view filing)Aug 12-132 daysJones Evan/ FaDirectorSSale−20.6K$32.20−$661.8K−37.4%34.3K after4 lots10b5-1
Aug 14, 2024 (view filing)Aug 12-132 daysJones Evan/ FaDirectorSSale−27.3K$32.20−$878.7K−84.1%5.17K after4 lots10b5-1
Aug 13, 2024 (view filing)Aug 94 daysJones Evan/ FaDirectorSSale−1.03K$30.03−$31.0K−2.2%46.4K after10b5-1
Aug 13, 2024 (view filing)Aug 94 daysJones Evan/ FaDirectorSSale−746$30.03−$22.4K−2.2%32.5K after10b5-1
Aug 13, 2024 (view filing)Aug 76 daysJones Evan/ FaDirectorSSale−3.14K$30.32−$95.3K−6.3%47.1K afterAmended10b5-1
Aug 13, 2024 (view filing)Aug 76 daysJones Evan/ FaDirectorSSale−1.97K$30.32−$59.6K−5.6%33.2K afterAmended10b5-1
Aug 9, 2024 (view filing)Aug 72 daysHolstein JensDirectorSSale−5.00K$29.00−$145.0K−15.2%27.9K after2 lots10b5-1
Jul 18, 2024 (view filing)Jul 162 daysEastham KarinDirectorSSale−7.50K$25.00−$187.5K−18.4%33.2K after10b5-1
Jul 18, 2024 (view filing)Jul 162 daysLeite JohnChief Commercial Officer-CLIASSale−1.28K$25.00−$31.9K−1.5%83.0K after10b5-1
Jul 18, 2024 (view filing)Jul 162 daysHolstein JensDirectorSSale−5.00K$24.50−$122.5K−13.2%32.9K after2 lots10b5-1
Jun 13, 2024 (view filing)Jun 112 daysEastham KarinDirectorSSale−3.87K$20.59−$79.7K−11.7%29.3K after10b5-1
Jun 11, 2024 (view filing)Jun 101 dayBhanji MunaDirectorSSale−3.87K$20.32−$78.6K−14.3%23.1K after10b5-1
Jun 11, 2024 (view filing)Jun 74 daysEastham KarinDirectorSSale−2.50K$20.97−$52.4K−7.0%33.1K after10b5-1
May 30, 2024 (view filing)May 282 daysBhanji MunaDirectorSSale−1.54K$21.00−$32.3K−5.4%27.0K after10b5-1
Apr 2, 2024 (view filing)Apr 11 dayEastham KarinDirectorSSale−10.0K$21.65−$216.5K−23.2%33.1K after
Mar 5, 2024 (view filing)Mar 14 daysJones Evan/ FaDirectorSSale−10.0K$24.36−$243.6K−21.0%37.6K after
Jul 24, 2023 (view filing)Jul 195 daysLateJones Evan/ FaDirectorSSale−838$30.14−$25.3K−2.2%37.6K after
Jul 24, 2023 (view filing)Jul 195 daysLateJones Evan/ FaDirectorSSale−3.09K$30.17−$93.2K−8.1%35.2K after
Jul 19, 2023 (view filing)Jul 17-182 daysBishop John LDirectorSSale−20.0K$30.25−$605.0K−37.6%33.1K after2 lots10b5-1
Jul 19, 2023 (view filing)Jul 17-182 daysJones Evan/ FaDirectorSSale−21.4K$30.08−$644.3K−35.8%38.4K after2 lots
Jul 19, 2023 (view filing)Jul 17-182 daysJones Evan/ FaDirectorSSale−31.4K$30.10−$944.8K−45.1%38.3K after2 lots
Jun 21, 2023 (view filing)Jun 165 daysBhanji MunaDirectorSSale−5.89K$26.43−$155.8K−17.1%28.5K after2 lots10b5-1
Jun 1, 2023 (view filing)May 302 daysBhanji MunaDirectorSSale−1.54K$25.91−$39.9K−5.9%24.7K after
Apr 18, 2023 (view filing)Apr 144 daysAnderson Bonnie HDirectorSSale−34.0K$22.04−$749.4K−44.3%42.7K after
Mar 17, 2023 (view filing)Mar 161 dayEastham KarinDirectorSSale−18.8K$22.78−$427.1K−44.4%23.5K after
Mar 16, 2023 (view filing)Mar 151 dayAnderson Bonnie HDirectorSSale−34.0K$22.76−$773.8K−38.7%54.0K after
Mar 2, 2023 (view filing)Feb 282 daysEastham KarinDirectorSSale−10.0K$25.00−$250.0K−29.9%23.5K after
Jan 18, 2023 (view filing)Jan 171 dayAnderson Bonnie HDirectorSSale−34.0K$26.34−$895.7K−35.1%63.0K after2 lots
Jan 12, 2023 (view filing)Jan 111 dayAnderson Bonnie HDirectorSSale−63.2K$25.13−$1.59M−50.1%63.0K after
Dec 16, 2022 (view filing)Dec 142 daysJones Evan/ FaDirectorSSale−600$30.13−$18.1K−1.2%50.2K after
Dec 15, 2022 (view filing)Dec 132 daysJones Evan/ FaDirectorSSale−1.67K$30.72−$51.2K−3.2%50.8K after2 lots
Dec 8, 2022 (view filing)Dec 62 daysKennedy Giulia CChief Scientific & Med OfficerSSale−1.02K$27.03−$27.7K−1.5%66.0K after
Dec 5, 2022 (view filing)Dec 14 daysAnderson Bonnie HExecutive ChairwomanSSale−80.0K$28.26−$2.26M−55.2%65.0K after2 lots
Nov 15, 2022 (view filing)Nov 114 daysKennedy Giulia CChief Scientific & Med OfficerSSale−2$29.34−$58.680.0%68.0K after
Nov 15, 2022 (view filing)Nov 114 daysJones Evan/ FaDirectorSSale−6.00K$30.22−$181.3K−10.3%52.5K after2 lots
Nov 8, 2022 (view filing)Nov 44 daysKennedy Giulia CChief Scientific & Med OfficerSSale−1.02K$25.00−$25.6K−1.5%68.0K after
Aug 9, 2022 (view filing)Aug 5-84 daysAnderson Bonnie HExecutive ChairwomanSSale−121.9K$27.56−$3.36M−52.0%112.4K after3 lots
Aug 9, 2022 (view filing)Aug 54 daysKennedy Giulia CChief Scientific & Med OfficerSSale−1.03K$26.54−$27.3K−1.4%70.0K after
Jun 16, 2022 (view filing)Jun 142 daysHolstein JensDirectorSSale−8.72K$16.27−$141.9K−81.3%2.00K after